|
Pharmacological Group: Immunosuppressants, Active Ingredient: Basiliximab, Pharmaceutical Form: Injectable Lyophil Powder, Concentration / Dosage: 20, Unit: Mg, Volume: Not Applicable, Presentation: Fr, Accessory: Not Applicable, Pharmacological Group: Antineoplastics, Active Ingredient: Sulfate Of Bleomycin, Concentration/Dosage: 15, Unit: U, Presentation: Vial-Ampule, Accessory: N/A, Active Ingredient: Carboplatin, Pharmaceutical Form: Injectable Solution, Concentration / Dosage: 10Mg/Ml, Unit: Mg/Ml, Volume: 45 Ml, Presentation: Ampoule Bottle, Accessory: N/A, Active Ingredient: Cyclosporine, Pharmaceutical Form: Oral Solution With Microemulsion, Concentration / Dosage: 100, Volume: 50Ml, Presentation: Bottle, Accessory: Dosage, Active Ingredient: Cyproterone Acetate, Pharmaceutical Form: Tablet, Concentration / Dosage: 50, Presentation: Not Applicable, 09/01/ 2025, Active Ingredient: Chlorambucil, Concentration / Dosage: 2, Pharmacological Group: Anticonvulsants, Active Ingredient: Phenobarbital Sodium, Volume: 2Ml, Presentation: Ampoule, Pharmacological Group: Antipsychotics, Active Ingredient: Haloperidol, Concentration / Dosage: 5, Volume: 1Ml
|
